Stonepine Capital, L.P. insider trades: Novelion Therapeutics (NVLNF) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Stonepine Capital, L.P. reports to the SEC
Open-market buys and sales
15 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Dec 12, 2019 | NVLNF | ↑ Buy | 6,242 | $0.69 | $4K | Direct | Dec 12, 2019 (0d) |
| Dec 9, 2019 | NVLNF | ↑ Buy | 9,700 | $0.70 | $7K | Direct | Dec 9, 2019 (0d) |
| Nov 22, 2019 | NVLNF | ↑ Buy | 89,845 | $0.75 | $67K | Direct | Nov 26, 2019 (4d) |
| Oct 11, 2019 | NVLNF | ↑ Buy | 100,000 | $0.65 | $65K | Direct | Oct 16, 2019 (5d) |
| Dec 27, 2018 | APEN | ↓ Sell | 250,000 | $3.00 | $750K | Direct | Dec 31, 2018 (4d) |
| Dec 26, 2018 | APEN | ↓ Sell | 500,000 | $3.00 | $1.5M | Direct | Dec 28, 2018 (2d) |
| Nov 21, 2018 | APEN | ↑ Buy | 57,430 | $3.41 | $196K | Direct | Nov 21, 2018 (0d) |
| Nov 2, 2018 | APEN | ↑ Buy | 300,000 | $5.00 | $1.5M | Direct | Nov 6, 2018 (4d) |
| Jan 3, 2018 | APEN | ↑ Buy | 22,845 | $5.71 | $130K | Direct | Jan 3, 2018 (0d) |
| Dec 26, 2017 | APEN | ↑ Buy | 5,287 | $5.00 | $26K | Direct | Dec 28, 2017 (2d) |
| Dec 22, 2017 | APEN | ↑ Buy | 185,157 | $4.85 | $897K | Direct | Dec 22, 2017 (0d) |
| Mar 17, 2017 | VIVE | ↑ Buy | 1,250,000 | $4.00 | $5.0M | See Notes | Mar 21, 2017 (4d) |
| Sep 15, 2016 | QLTI | ↑ Buy | 133,496 | $1.55 | $207K | Direct | Sep 15, 2016 (0d) |
| Jun 17, 2016 | VIVE | ↑ Buy | 300,000 | $5.00 | $1.5M | See | Jun 21, 2016 (4d) |
| Nov 24, 2015 | VIVMF | ↑ Buy | 2,857,142 | $0.70 | $2.0M | Direct | Nov 25, 2015 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Stonepine Capital, L.P.'s insider trades
Stonepine Capital, L.P. is a 10% owner of Novelion Therapeutics (NVLNF). Since Nov 24, 2015, it has reported 13 open-market purchases worth $11.6M and 2 sales worth $2.3M on SEC Form 4. There have been no open-market trades in the last 12 months.
Its filings also include shares returned to the company (1 filing), other transactions (1 filing), grants and awards (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every NVLNF insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.